US 8486965
Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8486965 (Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer) held by Takeda Pharmaceutical Company Limited expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P43/00